A marker of inflammation, transcription factor NF-κB-p65 protein, was decreased in COPD–primary bronchial fibroblasts at 24 h after ESW treatment, but it was increased in CS–primary bronchial fibroblasts and in bronchial epithelial cells after ESW treatment. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.